Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium

Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium

Abstract Background Immune checkpoint inhibitors (ICIs) have contributed to a significant advancement in the treatment of cancer, leading to improved clinical outcomes in many individuals with advanced disease. Both preclinical and clinical investigations have shown that ICIs are associated with ath...

Full description

Bibliographic Details
Main Authors: Bingxin Gong, Yusheng Guo, Yi Li, Jing Wang, Guofeng Zhou, Yong-hao Chen, Tong Nie, Ming Yang, Kun Luo, Chuansheng Zheng, Feng Pan, Bo Liang, Lian Yang
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Medicine
Subjects:
Atherosclerosis
Immunotherapy
Cardiovascular disease
Coronary artery calcium
Imaging
Online Access:https://doi.org/10.1186/s12916-024-03261-x

Internet

https://doi.org/10.1186/s12916-024-03261-x

Similar Items